Vicrostatin – An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities

Radu O. Minea, Corey M. Helchowski, Samuel J. Zidovetzki et al. · 2010

Read Vicrostatin – An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities by Radu O. Minea, Corey M. Helchowski, Samuel J. Zidovetzki et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010929.txt.

Description

Radu Minea, Corey Helchowski, Samuel Zidovetzki and co-authors published this cancer drug study in PLOS ONE in 2010. Disintegrins, proteins from snake venom, can block integrins, the anchors cells use to grip tissue and blood vessels, and they have slowed tumors in animals. Making them in the lab is notoriously hard because their many internal bonds must pair exactly right.

The team engineered a chimera called vicrostatin and produced it reliably at scale inside modified bacteria. The molecule grabs three integrin types at once, hitting both tumor cells and the endothelial cells that build new blood vessels. Through a recreated tissue barrier it sharply reduced cell movement, and it also showed vessel-starving and cell-death effects. Minea and colleagues turn a finicky venom protein into a manufacturable drug candidate.

Catalog record

CREATORRadu O. Minea, Corey M. Helchowski, Samuel J. Zidovetzki et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE104 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010929

Browse the full library · About the Tower of Babel